Bookmark and Share
Print This Page
Last updated: 02-14-2012
A A A A

Joseph P. Catlett, MD

Clinical Expertise

  • Leukemia, lymphoma, myeloma, benign hematology

Practice Focus

  • Leukemia, lymphoma, myeloma, benign hematology/coagulation

Education:

  • BS from Shepherd College, Shepherdstown, WV, 1980, Cum Laude
  • MD from West Virginia University School of Medicine, Morgantown, WV, 1984

Residency

  • Internal Medicine: West Virginia University Hospitals

Fellowship

  • Medical College of Virginia/Virginia Commonwealth University

Credentialed Areas

  • LICENSURE
    • Virginia, Registration No. 0101040900, Exp 3/31/2008
    • District of Columbia No. 20542, Exp 12/31/2008
    • National Board of Medical Examiners, Parts I, II, III
  • BOARD CERTIFICATION
    • Internal Medicine, September 1987
    • Medical Oncology, November 1989
    • Hematology, November 1990; Re-certification 5/1/01

Honors, Awards & Society Memberships

  • HONORS AND AWARDS
    • Alpha Omega Alpha, 1987
    • Excellence in Outpatient Medicine Award, WVU, 1985
    • Resident Teaching Award, Internal Medicine, WVU, 1986-1987
    • Robert H. Waldman Research/Academic Excellence Award, WVU, 1986-1987
  • PROFESSIONAL AND SOCIETY MEMBERSHIPS
    • Fellow, American College of Physicians
    • Member, American Society of Hematology
    • Member, American Society of Clinical Oncology
  • TEACHING/ PROFESSIONAL RESPONSIBILITIES
    • Attending Physician, Section of Hematology and Medical Oncology responsible for the education and training of Fellows in Hematology and Medical Oncology from MedStar Washington Hospital Center, Georgetown University, and the National Heart, Lung and Blood Institute of the National Institutes of Health, and medical students, and residents from MedStar Washington Hospital Center, Georgetown University, Howard University and Uniformed Services University of the Health Sciences who rotate on the Hematology Service.
    • Teaching Attending, General Internal Medicine Service, Department of Internal Medicine for MedStar Washington Hospital Center residents and medical students from Georgetown University, Howard University, and Uniformed Services University of the Health Sciences
    • Core Lecture Series in Hematology for Medical Residents, Department of Medicine, MedStar Washington Hospital Center, Washington, DC
    • Core Lecture Series for Fellows in Hematology/Medical Oncology, Section of Hematology and Medical Oncology, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC
    • Hematopathology Conference for Fellows in Hematology/Medical Oncology, Section of Hematology and Medical Oncology, MedStar Washington Hospital Center, Washington, DC
    • Internal Medicine Board Review, Hematology Section, MedStar Washington Hospital Center, Washington, DC
    • Co-Director, Hematology Clinic, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC
    • Board Review for Hematology Fellows on a continuous basis.
  • COMMITTEES
    • Co-Chairman, Oncology Drug Utilization Management Task Force, MedStar Washington Hospital Center; 1994.
    • Member, Institutional Review Board, MedStar Washington Hospital Center; July 1995 to June 1999.
    • Chair, Graduate Medical Education Committee of the Department of Medicine, MedStar Washington Hospital Center, Washington, DC; July 1996 to 2000.
    • Member, Pharmacy and Therapeutics Committee, MedStar Washington Hospital Center, Washington, DC; January 1998 to present.

LOCAL, REGIONAL, NATIONAL PRESENTATIONS

  • "Toxic Encephalopathy and Cerebrospinal Fluid Pleocytosis as the Initial Manifestations of Infective Endocarditis: A Case Report." Regional Meeting of the American College of Physicians, October 1985, Morgantown, WV.
  • "Liddle's Syndrome." Regional Meeting of the American College of Physicians, October 1985, Morgantown, WV.
  • "Various Antimicrobials Alone and in Combination Against Clinical Isolates of Pseudomonas cepacia ." Catlett, J., McDaniel, J., Padden, S., and Khakoo, R., American Society for Microbiology, (Poster) March 1987, Atlanta, Georgia
  • "Hemolytic Uremic Syndrome in Bone Marrow Transplant Patients." Virginia Society of Hematology, June 9, 1989, Virginia Beach, VA.
  • "Hemolytic Uremic Syndrome." Clinicopathological Conference, West Virginia University Health Sciences Center, January 23, 1990, Morgantown, WV.
  • "C- kit Expression by CD 34+ Bone Marrow Progenitors and Inhibition of Response to rhIL-3 Following Exposure to Antisense Oligonucleotides to c- kit ," Scientific Session, American Society of Hematology, December 1990, Boston, MA.
  • "C- kit in Normal and Abnormal Myelopoiesis." Division of Hematology/Oncology Research Seminar, Medical College of Virginia, December 12, 1990, Richmond, VA.
  • "The c- kit Proto-Oncogene in Normal Hematopoiesis." Research Seminar, Food and Drug Administration, Research Division, September 12, 1991, Washington, D.C.
  • "New Clinical Endpoints for Efficacy," FDA Oncologic Drugs Advisory Committee Meeting, June, 1992, Rockville, MD.
  • "Review of the Current Status of Toremifene." FDA Oncologic Drugs Advisory Committee Meeting, October, 1992, Rockville, MD.
  • Supplemental New Drug Application: Blenoxane for Use as a Sclerosing Agent in the Management of Malignant Pleural Effusions, FDA Oncologic Drugs Advisory Committee, September 23, 1993, Rockville, MD.
  • New Drug Application: Navelbine for Treatment of Inoperable and Advanced Non-Small Cell Lung Cancer, FDA Oncologic Drugs Advisory Committee, December 15, 1993, Rockville, MD.
  • "Evaluation of Anemia in a College-Age Population." University of Maryland Health Center, December 13, 1994, College Park, MD.
  • "Diabetes Insipidus Secondary to Leukemic Infiltration of the Central Nervous System in a Patient With Acute Myelomonocytic Leukemia." Chhabra G, Lessin L, Catlett J . (Poster) Regional Meeting of the American College of Physicians, Washington Metropolitan Region, May 1995, Bethesda, Maryland.
  • "Thrombopoietins: An Update." Tumor Board, Washington Cancer Institute, September 1, 1995, Washington, DC.
  • "Peripheral Neuropathy Associated with Castleman's Disease (CD): A Rare Paraneoplastic Syndrome." Hashim A, Laureno R, Nam L, Catlett J . Poster Session, Regional Meeting of the American College of Physicians, Washington Metropolitan Region, May 11, 1996, Bethesda, Maryland.
  • "Treatment of Aggressive Lymphomas." Tumor Board, Washington Adventist Hospital, May 17, 1996, Takoma Park, MD.
  • “Clinical Pathways for Melanoma.” Multidisciplinary Management of Malignant Melanoma, May 9, 1998, Hot Springs, VA.
  • “Plasma Thrombopoietin Levels and Glycocalicin Indexes in Thrombocytopenic Patients with Alcoholic Liver Disease.” Mendoza J, Catlett J , Williams S, Rivera C. Scientific Session, XVII Congress of the International Society on Thrombosis and Haemostasis, August 16, 1999, Washington, D.C.
  • “Update in Hematology.” American College of Physicians/American Society of Internal Medicine National Meeting, March 29, 2001, Atlanta, GA.
  • Discussant, Myelodysplasia Section of Highlights of the American Society of Hematology Meeting, McLean, VA , March 2002.
  • “Infusional Chemotherapy Combined with Rituximab is Effective Therapy for Post-Transplant Lymphoproliferative Disorder (PTLD)." Patel M, Light J, Catlett J . American Society of Transplant Surgeons, January 26, 2003, Miami Beach, FL.
  • Discussant, Myeloma Section of Highlights of the American Society of Hematology Meeting, McLean, VA, March, 2003.
  • Faculty Member, MedStar Washington Hospital Center's Preparation for Recertification in Internal Medicine Course, Hematology Board Review Presentation, Crystal City, VA, March, 2003.
  • Discussant, Myeloma Section of Highlights of the American Society of Hematology Meeting, McLean, VA, March 2004.
  • Faculty Member, MedStar Washington Hospital Center's Preparation for Recertification in Internal Medicine Course, Hematology Board Review Presentation, Crystal City, VA, March, 2004.
  • Discussant, Myeloma Section of Highlights of the American Society of Hematology Meeting, McLean, VA, March 2005.
  • Discussant, Myeloma Section of Highlights of the American Society of Hematology Meeting, McLean, VA, March 2006.
  • “Primary Lymphoma of Bone: An Institutional Experience.” O'Connor S, Williams S, Catlett J ., Podium Presentation, Regional Meeting of the American College of Physicians/American Society of Internal Medicine, Bethesda, MD, November, 2006.
  • Discussant, Myeloma Section of Highlights of the American Society of Hematology Meeting, McLean, VA, March 2007.
  • Faculty Member, 1 st Annual Multidisciplinary Management of Cancers: a Case-based Approach Symposium, Washington, D.C., October 27, 2007.

PUBLICATIONS

  • Catlett J , Ullrich I, Vasquez A. Ketotic Hypoglycemia. WV Medical Journal 1983;79:126-128.
  • Catlett J , Mckinnon G. Adjuvant Chemotherapy of Breast Cancer. Cancer News Quarterly 1988;7:1-3.
  • Catlett JP , Leftwich JA, Westin EH, Grant S, Huff TF. c- kit Expression by CD34 + Bone Marrow
  • Progenitors and Inhibition of Response to rhIL-3 Following Exposure to c- kit Antisense
  • Oligonucleotides. Blood 1991;78:3186-3191.
  • Catlett J , Carr ME, Todd WM. Merkel Cell Tumor in an HIV Positive Patient. Virginia Medical
  • Quarterly 1992;119:256-258.
  • Plummer H, Catlett J , Leftwich J, Armstrong B, Westin E, Huff T, Krystal G. Correlation of
  • myc Family Expression with the Regulation of a Potential c- kit /Stem Cell Factor Autocrine Growth Loop in Small Cell Lung Cancer. Cancer Research 1993;53:4337-4342.
  • Singh V, Catlett J . Hematologic Manifestations of Thyroid Disease. The Endocrinologist
  • 1998;8:87-91.
  • Chuu WM, Catlett J , Perry DJ et al. Concurrent Pneumocystis carinii and Cytomegalovirus
  • Pneumonia After Autologous Peripheral Blood Stem Cell Transplantation. Bone Marrow
  • Transplantation 1999;23:1087-1089.
  • Sanjeevi AR, Krishnan J, Bailey P, Catlett J . Extranodal Marginal Zone B-Cell Lymphoma of
  • Malt Type Involving the Cavernous Sinus. Leukemia and Lymphoma 2001;00:1-5.
  • Catlett J , Alving B. Update in Hematology. Ann Intern Med. 2002;136:136-143.
  • Aggarwal A, Catlett J . Rituximab: An Anti-CD20 Antibody for Treatment of Chronic Refractory Immune Thrombocytopenic Purpura. Southern Medical Journal 2002:95; 1209-12.
  • Aggarwal A, Malkovska V, Catlett J , Alcorn K. Recombinant Activated Factor VII (rFVIIa) as Salvage Treatment for Intractable Hemorrhage. Thrombosis Journal 2004:2; 9.

BOOK CHAPTERS

  • Petz L, Catlett J , Lessin L. Chapter 245: Hemolytic Anemias. In: Textbook of Internal Medicine
  • 3rd ed, edited by WN Kelly. Philadelphia:Lippincott, copyright 1997.
  • Catlett J. Hemolytic Anemias. In: Kelley's Textbook of Internal Medicine . 4th ed, edited by HD
  • Humes. Philadelphia:Lippincott, copyright 2000.

ABSTRACTS

  • "Various Antimicrobials Alone and in Combination Against Clinical Isolates of Pseudomonas cepacia ." Catlett J , McDaniel J, Padden S, Khakoo R. Abstracts of the American Society for Microbiology, #A12, March 1987.
  • "Expression of c- kit by CD34 + Bone Marrow Progenitors and Responses to rhIL-3 Following Exposure to Antisense Oligonucleotides to c- kit ." Catlett JP , Leftwich JA, Westin EH, Grant S, Huff TF. Blood 76:335a, November 1990.
  • "A Role for c- kit and Stem Cell Factor Expression in Autocrine Growth Stimulation of Small Cell Lung Cancer." Catlett JP , Leftwich J, Armstrong B, Westin E, Huff T, Krystal G. Proceedings of the American Association for Cancer Research 33:370, March 1992.
  • “A Phase II Study of PSC 833 (PSC) and VAD Chemotherapy in Patients With VAD-Refractory Multiple Myeloma (MM).” Case DC, Jain V, Stiff P, Janesn J, Stewart AK, Shurafa M, Hussein M, Heffner LT, Irwin D, Greipp P, Dalton W, Friedenberg W, Gucalp R, Anderson K, Catlett J , et al. Blood 92:#427, 1998.
  • “Use of Recombinant Activated FVII (fFVIIa) in the Management of Intractable Bleeding in Surgical and Trauma Patients.” Aggarwal A, Catlett J , Alcorn K. Blood 98: #3883, 2001.
  • “Primary Lymphoma of Bone: An Institutional Experience.” Mendoza J, Sanjeevi A, Catlett J . Blood 100: #4695, 2002.

GRANTS

  • American Cancer Society Institutional Grant - 1990-1991, Grant #IN-00105-16, Principal Investigator - Harry Bear, MD, PhD.
  • NHLBI Clinical Investigator Award, Sponsor: Thomas F. Huff, PhD - 1992, "C-kit in Normal and Abnormal Hematopoiesis."

Additional Training, Education & Research

  • POSTDOCTORAL TRAINING
    • Residency, Internal Medicine, West Virginia University Hospitals, Morgantown, West Virginia
    • Clinical Fellow in Hematology/Oncology, Medical College of Virginia, Richmond, Virginia
    • Research Fellow in Hematology/Oncology, Preceptors: Thomas F. Huff, PhD (Dept. of Microbiology/Immunology), Steven Grant, MD (Departments of Hematology/Oncology and Pharmacology/Toxicology), Bone Marrow Transplantation Laboratory, Medical College of Virginia, Richmond, Virginia
  • PROFESSIONAL POSITIONS
    • Staff Physician (Part-Time), Patient First Corporation, Richmond, VA
    • Instructor in Medicine, Division of Hematology/Oncology, Medical College of Virginia
    • Attending Staff, Medical Service, Hunter Holmes McGuire VAMC, Richmond, Virginia
    • Medical Officer, Center for Drug Evaluation and Research, Division of Oncology and Pulmonary Drug Products, United States Food and Drug Administration, Rockville, MD
    • Attending Staff, Medical Service, Division of Oncology, Veterans Administration Medical Center, Washington, D.C.
    • 1994-present: Attending Staff, Section of Hematology/Medical Oncology, MedStar Washington Hospital Center, Washington, D.C.
    • 1997-present: Assistant Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
110 Irving Street, NW · Washington, DC 20010 · MedStar Washington Hospital Center · (202) 877-7000